StockData
Immunome Inc. logo

Immunome Inc. (IMNM) stock

IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$16.78−0.40 (-2.33%)

Close on Nov 18, 2026Market cap $1.91BP/E –Yield –

Immunome price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Immunome's price to sales ratio was 373.9× on Apr 30, 2026, against 62.7× a year earlier. Over the last 2 years it ranged from 43.4× to 373.9×, with a median of 74.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 2026373.9×+170.4
2025Dec 31, 2025203.5×+140.2
2024Dec 31, 202463.4×–

More Immunome figures

See a number that looks wrong?